Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B5d84ceb0fc73b3282b0d21bb2588780d> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B5d84ceb0fc73b3282b0d21bb2588780d NCIT_P378 "NCI" @default.
- B5d84ceb0fc73b3282b0d21bb2588780d type Axiom @default.
- B5d84ceb0fc73b3282b0d21bb2588780d annotatedProperty IAO_0000115 @default.
- B5d84ceb0fc73b3282b0d21bb2588780d annotatedSource NCIT_C106120 @default.
- B5d84ceb0fc73b3282b0d21bb2588780d annotatedTarget "An orally available spiro-oxindole HDM2 (human double minute 2) antagonist with potential antineoplastic activity. Upon oral administration, the p53-HDM2 protein-protein interaction inhibitor MI-773 binds to HDM2, preventing the binding of the HDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this HDM2-p53 interaction, the proteasome-mediated enzymatic degradation of p53 is inhibited and the transcriptional activity of p53 is restored, which may result in the restoration of p53 signaling and lead to the p53-mediated induction of tumor cell apoptosis. HDM2, a zinc finger protein and a negative regulator of the p53 pathway, is often overexpressed in cancer cells. It has been implicated in cancer cell proliferation and survival." @default.